메뉴 건너뛰기




Volumn 223, Issue 5, 2011, Pages 565-566

Unveiling the molecular pathogenesis of chordoma: A new paradigm for molecular targeting of rare cancers

Author keywords

Chordoma; EGFR; Rare cancer; T; Target therapy

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; IMATINIB; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B INHIBITOR; RAS PROTEIN; TYRPHOSTIN;

EID: 79952570454     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2847     Document Type: Note
Times cited : (11)

References (11)
  • 2
    • 33845787013 scopus 로고    scopus 로고
    • Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma
    • DOI 10.1159/000096283
    • Hof H, Welzel T, Debus J. Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma. Onkologie 2006; 29: 572-574. (Pubitemid 46005781)
    • (2006) Onkologie , vol.29 , Issue.12 , pp. 572-574
    • Hof, H.1    Welzel, T.2    Debus, J.3
  • 4
    • 78650597625 scopus 로고    scopus 로고
    • Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: A genetic and functional-based study
    • Presneau N, Shalaby A, Ye H, et al. Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study. J Pathol 2011; 223: 327-335.
    • (2011) J Pathol , vol.223 , pp. 327-335
    • Presneau, N.1    Shalaby, A.2    Ye, H.3
  • 5
    • 78650600886 scopus 로고    scopus 로고
    • The role of epidermal growth factor receptor in chordoma pathogenesis: A potential therapeutic target
    • Shalaby A, Presneau N, Ye H, et al. The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target. J Pathol 2011; 223: 336-346.
    • (2011) J Pathol , vol.223 , pp. 336-346
    • Shalaby, A.1    Presneau, N.2    Ye, H.3
  • 6
    • 77956923738 scopus 로고    scopus 로고
    • Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas
    • Tamborini E, Virdis E, Negri T, et al. Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas. Neurol Oncol 2010; 12: 776-789.
    • (2010) Neurol Oncol , vol.12 , pp. 776-789
    • Tamborini, E.1    Virdis, E.2    Negri, T.3
  • 8
    • 71049122718 scopus 로고    scopus 로고
    • Response to imatinib plus sirolimus in advanced chordoma
    • Stacchiotti S, Marrari A, Tamborini E, et al. Response to imatinib plus sirolimus in advanced chordoma. Ann Oncol 2009; 20: 1886-1894.
    • (2009) Ann Oncol , vol.20 , pp. 1886-1894
    • Stacchiotti, S.1    Marrari, A.2    Tamborini, E.3
  • 9
    • 77953500058 scopus 로고    scopus 로고
    • Do rare cancers deserve specific strategies for cancer research?
    • Casali PG. Do rare cancers deserve specific strategies for cancer research? Lancet Oncol 2010; 11: 506-507.
    • (2010) Lancet Oncol , vol.11 , pp. 506-507
    • Casali, P.G.1
  • 10
    • 79952551055 scopus 로고    scopus 로고
    • last accessed 20 December 2010
    • http://www.rarecancers.eu [last accessed 20 December 2010].
  • 11
    • 79952554336 scopus 로고    scopus 로고
    • last accessed 20 December 2010
    • http://www.eurobonet.eu [last accessed 20 December 2010].


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.